title: Detection of Loss of Heterozygosity (LOH) Using Circulating Cell-free DNA (cfDNA) by Fluorescence-based Multiplex PCR for Identification of Patients With Prostate Cancer.
abstract: Several lines of evidence suggest that loss of heterozygosity (LOH) in specific chromosomal regions is a common mechanism for the inactivation of tumor-suppressor genes that are implicated in the pathogenesis of prostate cancer (PCa). Short tandem repeat (STR) sequences are extremely reliable genetic markers for the detection of LOH associated with cancers. Hence, in the current study, we investigated the detection of LOH at 6 STR markers (D8S360, D9S1748, D9S171, D8S137, D6S1631, and THRB) using blood circulating cell-free DNA (cfDNA), which can be used to distinguish PCa from benign prostatic hyperplasia (BPH). A total of 136 individuals were included in the study, 76 male patients diagnosed with PCa (50 male patients with localized PCa and 26 male patients with metastatic PCa) as experimental subjects and 60 male patients with BPH as controls. Circulating cfDNA was extracted from plasma samples and amplified with fluorescence-labeled primers specific for known STR markers. We also evaluated the serum prostate-specific antigen in both groups. Our findings revealed that the frequency of LOH at D8S360, D9S1748, D9S171, D8S137, and D6S1631 was significantly higher in PCa subjects than in controls (P<0.05). Of the 6 STR markers, LOH at D8S360 could discriminate metastatic PCa from localized PCa. We found that 71.05% of patients with PCa and 1.66% of BPH subjects had LOH at least at 3 of the markers in cfDNA. Our findings provide additional evidence to support the hypothesis that analysis of LOH at D8S360, D9S1748, D9S171, D8S137, and D6S1631 STR markers using cfDNA can be applied as a noninvasive diagnostic approach for the detection of PCa.
authors.affiliation: Department of Biology, Science and Research Branch, Islamic Azad University.
authors.forename: S-Maryam
authors.initials: SM
authors.lastname: Seyedolmohadessin
authors.affiliation: Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University.
authors.forename: Mohammad T
authors.initials: MT
authors.lastname: Akbari
authors.affiliation: Department of Biology, Science and Research Branch, Islamic Azad University.
authors.forename: Zahra
authors.initials: Z
authors.lastname: Nourmohammadi
authors.affiliation: Urology and Nephrology Research Center, Shahid-Beheshti University of Medical Sciences.
authors.forename: Abbas
authors.initials: A
authors.lastname: Basiri
authors.affiliation: Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
authors.forename: Gholamreza
authors.initials: G
authors.lastname: Pourmand
mesh_terms: D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood / Q000235:genetics; D000074141:Circulating Tumor DNA / Q000097:blood / Q000235:genetics; D005453:Fluorescence; D006801:Humans; D019656:Loss of Heterozygosity; D008297:Male; D018895:Microsatellite Repeats; D008875:Middle Aged; D060885:Multiplex Polymerase Chain Reaction; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis / Q000235:genetics
chemical_list: D014408:Biomarkers, Tumor; D000074141:Circulating Tumor DNA